Insider · CIK 0001813574

Valliant John

Reports to the SEC for 1 company · HAMILTON, A6

sec.gov

Transactions

Companies

Filings

CIK

0001813574

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2024-06-04	Fusion Pharmaceuticals Inc.D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−318K sh	—	—	0
2024-06-04	Fusion Pharmaceuticals Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−533K sh	—	—	0
2024-06-04	Fusion Pharmaceuticals Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−270K sh	—	—	0
2024-06-04	Fusion Pharmaceuticals Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−607K sh	—	—	0
2024-06-04	Fusion Pharmaceuticals Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−174K sh	—	—	0
2024-06-04	Fusion Pharmaceuticals Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−207K sh	—	—	0
2024-06-04	Fusion Pharmaceuticals Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−373K sh	—	—	0
2024-06-04	Fusion Pharmaceuticals Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−336K sh	—	—	0
2024-06-04	Fusion Pharmaceuticals Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−407K sh	—	—	0
2024-06-04	Fusion Pharmaceuticals Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−500K sh	—	—	0
2024-06-04	Fusion Pharmaceuticals Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−320K sh	—	—	0
2024-06-04	Fusion Pharmaceuticals Inc.Restricted Stock UnitsD Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−192K sh	—	—	0
2024-01-04	Fusion Pharmaceuticals Inc.Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+320K sh	—	—	320,400
2024-01-04	Fusion Pharmaceuticals Inc.Restricted Stock UnitsA Award	Director, Chief Executive Officer	AAward	+192K sh	—	—	192,200
2023-01-05	Fusion Pharmaceuticals Inc.Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+500K sh	—	—	500,000
2022-04-27	Fusion Pharmaceuticals Inc.S Sale	Director, Chief Executive Officer	SSale	−4,511 sh	$6.03	−$27.2K	318,147
2022-04-26	Fusion Pharmaceuticals Inc.S Sale	Director, Chief Executive Officer	SSale	−2,147 sh	$6.07	−$13K	322,658
2022-04-25	Fusion Pharmaceuticals Inc.S Sale	Director, Chief Executive Officer	SSale	−2,036 sh	$6.03	−$12.3K	324,805
2022-04-21	Fusion Pharmaceuticals Inc.S Sale	Director, Chief Executive Officer	SSale	−922 sh	$6.01	−$5,541.22	326,841
2022-04-20	Fusion Pharmaceuticals Inc.S Sale	Director, Chief Executive Officer	SSale	−367 sh	$6.02	−$2,209.34	327,763
2022-04-13	Fusion Pharmaceuticals Inc.S Sale	Director, Chief Executive Officer	SSale	−12K sh	$6.41	−$76.9K	328,130
2022-04-12	Fusion Pharmaceuticals Inc.S Sale	Director, Chief Executive Officer	SSale	−18.3K sh	$7.10	−$130K	340,124
2022-04-11	Fusion Pharmaceuticals Inc.S Sale	Director, Chief Executive Officer	SSale	−2,600 sh	$7.37	−$19.2K	358,379
2022-04-08	Fusion Pharmaceuticals Inc.S Sale	Director, Chief Executive Officer	SSale	−826 sh	$7.52	−$6,211.52	360,979
2022-04-07	Fusion Pharmaceuticals Inc.S Sale	Director, Chief Executive Officer	SSale	−1,255 sh	$7.56	−$9,487.8	361,805
2022-04-06	Fusion Pharmaceuticals Inc.S Sale	Director, Chief Executive Officer	SSale	−100 sh	$7.58	−$758	363,060
2022-04-05	Fusion Pharmaceuticals Inc.S Sale	Director, Chief Executive Officer	SSale	−2,100 sh	$7.67	−$16.1K	363,160
2022-04-04	Fusion Pharmaceuticals Inc.S Sale	Director, Chief Executive Officer	SSale	−700 sh	$7.81	−$5,467	365,260
2022-04-01	Fusion Pharmaceuticals Inc.S Sale	Director, Chief Executive Officer	SSale	−1,000 sh	$7.75	−$7,750	365,960
2022-03-30	Fusion Pharmaceuticals Inc.S Sale	Director, Chief Executive Officer	SSale	−300 sh	$7.52	−$2,256	366,960
2022-03-29	Fusion Pharmaceuticals Inc.S Sale	Director, Chief Executive Officer	SSale	−200 sh	$7.52	−$1,504	367,260
2022-03-28	Fusion Pharmaceuticals Inc.S Sale	Director, Chief Executive Officer	SSale	−9,600 sh	$7.55	−$72.5K	367,460
2022-03-25	Fusion Pharmaceuticals Inc.S Sale	Director, Chief Executive Officer	SSale	−500 sh	$7.42	−$3,710	377,060
2022-03-23	Fusion Pharmaceuticals Inc.S Sale	Director, Chief Executive Officer	SSale	−100 sh	$7.50	−$750	378,260
2022-03-22	Fusion Pharmaceuticals Inc.S Sale	Director, Chief Executive Officer	SSale	−4,000 sh	$7.53	−$30.1K	378,360
2022-03-21	Fusion Pharmaceuticals Inc.S Sale	Director, Chief Executive Officer	SSale	−700 sh	$7.46	−$5,222	377,560
2022-03-21	Fusion Pharmaceuticals Inc.S Sale	Director, Chief Executive Officer	SSale	−1,500 sh	$7.47	−$11.2K	382,360
2022-03-18	Fusion Pharmaceuticals Inc.S Sale	Director, Chief Executive Officer	SSale	−1,204 sh	$7.61	−$9,162.44	383,860
2022-03-17	Fusion Pharmaceuticals Inc.S Sale	Director, Chief Executive Officer	SSale	−900 sh	$7.51	−$6,759	385,064
2022-03-16	Fusion Pharmaceuticals Inc.S Sale	Director, Chief Executive Officer	SSale	−100 sh	$6.99	−$699	385,964
2022-03-15	Fusion Pharmaceuticals Inc.S Sale	Director, Chief Executive Officer	SSale	−100 sh	$7.12	−$712	386,064
2022-03-14	Fusion Pharmaceuticals Inc.S Sale	Director, Chief Executive Officer	SSale	−1,300 sh	$6.96	−$9,048	386,164
2022-03-11	Fusion Pharmaceuticals Inc.S Sale	Director, Chief Executive Officer	SSale	−100 sh	$7.13	−$713	387,464
2022-03-10	Fusion Pharmaceuticals Inc.S Sale	Director, Chief Executive Officer	SSale	−1,900 sh	$7.06	−$13.4K	387,564
2022-03-09	Fusion Pharmaceuticals Inc.S Sale	Director, Chief Executive Officer	SSale	−822 sh	$6.94	−$5,704.68	389,464
2022-03-08	Fusion Pharmaceuticals Inc.S Sale	Director, Chief Executive Officer	SSale	−3,004 sh	$6.92	−$20.8K	390,286
2022-03-07	Fusion Pharmaceuticals Inc.S Sale	Director, Chief Executive Officer	SSale	−3,100 sh	$6.99	−$21.7K	393,290
2022-03-04	Fusion Pharmaceuticals Inc.S Sale	Director, Chief Executive Officer	SSale	−8,400 sh	$7.32	−$61.5K	396,390
2022-03-03	Fusion Pharmaceuticals Inc.S Sale	Director, Chief Executive Officer	SSale	−200 sh	$7.28	−$1,456	404,790
2022-03-02	Fusion Pharmaceuticals Inc.S Sale	Director, Chief Executive Officer	SSale	−26.5K sh	$7.44	−$198K	404,990

Recent filings

Accepted (ET)
Jun 44
Valliant John0000950170-24-068905
SEC(opens sec.gov)
Jan 54
Valliant John0000950170-24-002291
SEC(opens sec.gov)
Jan 94
Valliant John0001209191-23-002499
SEC(opens sec.gov)
Apr 274
Valliant John0001209191-22-025783
SEC(opens sec.gov)
Apr 224
Valliant John0001209191-22-025469
SEC(opens sec.gov)

Companies

Fusion Pharmaceuticals Inc.Director, Chief Executive Officer

Address

C/O FUSION PHARMACEUTICALS INC. 270 LONGWOOD ROAD SOUTH

HAMILTON, A6, L8P 0A6